Company
Founded in 2016, Opharmic is striving towards an ambitious goal: to replace horrifying eye injections around the world with our patented non-invasive ultrasound system. Based on over a decade of research and development, the team has successfully developed extensive drug delivery applications in the ophthalmology space. From technology and product customisation, to clinical development and regulatory strategies, Opharmic offers turnkey solution to pharma partners around the world to adopt cutting-edge technology in their new or existing pipelines.
Description
Ultrasonic ocular drug delivery platform – a non-invasive alternative to eye injections
